会員登録
ログイン
【4503】アステラス製薬
製薬。泌尿器、移植、抗がん剤。
類似企業：
【業界1位】
武田薬品工業
【業界1位】
武田薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2024/10/30 | Q2予 | 1,800,000 | ↑ | +9.1% | +9.1% | 80,000 | ↑ | +66.7% | +66.7% | 70,000 | ↑ | +62.8% | +62.8% | 50,000 | ↑ | +66.7% | +66.7% |
| 2025.03 | 2024/08/01 | Q1予 | 1,650,000 | → | 0.0% | 0.0% | 48,000 | → | 0.0% | 0.0% | 43,000 | → | 0.0% | 0.0% | 30,000 | → | 0.0% | 0.0% |
| 2025.03 | 2024/04/25 | 当初予 | 1,650,000 | - | - | - | 48,000 | - | - | - | 43,000 | - | - | - | 30,000 | - | - | - |
| 2024.03 | 2024/04/25 | 実 | 1,603,672 | ↑ | +2.7% | +5.5% | 25,518 | ↑ | +96.3% | -91.1% | 24,969 | ↑ | +108.1% | -91.4% | 17,045 | ↑ | +468.2% | -92.5% |
| 2024.03 | 2024/04/12 | 修正予 | 1,562,000 | → | 0.0% | +2.8% | 13,000 | ↓ | -84.3% | -95.5% | 12,000 | ↓ | -85.4% | -95.8% | 3,000 | ↓ | -94.8% | -98.7% |
| 2024.03 | 2024/02/05 | Q3予 | 1,562,000 | ↓ | -2.9% | +2.8% | 83,000 | ↓ | -32.5% | -71.2% | 82,000 | ↓ | -32.2% | -71.6% | 58,000 | ↓ | -31.8% | -74.4% |
| 2024.03 | 2023/11/01 | Q2予 | 1,608,000 | ↑ | +5.8% | +5.8% | 123,000 | ↓ | -52.5% | -57.3% | 121,000 | ↓ | -53.5% | -58.1% | 85,000 | ↓ | -58.3% | -62.6% |
| 2024.03 | 2023/08/01 | Q1予 | 1,520,000 | → | 0.0% | 0.0% | 259,000 | ↓ | -10.1% | -10.1% | 260,000 | ↓ | -10.0% | -10.0% | 204,000 | ↓ | -10.1% | -10.1% |
| 2024.03 | 2023/04/27 | 当初予 | 1,520,000 | - | - | - | 288,000 | - | - | - | 289,000 | - | - | - | 227,000 | - | - | - |
| 2023.03 | 2023/04/27 | 実 | 1,518,619 | ↓ | -0.7% | +5.2% | 133,029 | ↓ | -2.9% | -50.5% | 132,361 | ↓ | -2.0% | -50.4% | 98,714 | ↓ | -6.0% | -52.5% |
| 2023.03 | 2023/04/11 | 修正予 | 1,529,000 | → | 0.0% | +6.0% | 137,000 | ↓ | -29.7% | -49.1% | 135,000 | ↓ | -30.1% | -49.4% | 105,000 | ↓ | -30.0% | -49.5% |
| 2023.03 | 2023/02/06 | Q3予 | 1,529,000 | → | 0.0% | +6.0% | 195,000 | ↓ | -27.5% | -27.5% | 193,000 | ↓ | -27.7% | -27.7% | 150,000 | ↓ | -27.9% | -27.9% |
| 2023.03 | 2022/10/31 | Q2予 | 1,529,000 | ↑ | +6.0% | +6.0% | 269,000 | → | 0.0% | 0.0% | 267,000 | → | 0.0% | 0.0% | 208,000 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/01 | Q1予 | 1,443,000 | → | 0.0% | 0.0% | 269,000 | → | 0.0% | 0.0% | 267,000 | → | 0.0% | 0.0% | 208,000 | → | 0.0% | 0.0% |
| 2023.03 | 2022/04/27 | 当初予 | 1,443,000 | - | - | - | 269,000 | - | - | - | 267,000 | - | - | - | 208,000 | - | - | - |
| 2022.03 | 2022/04/27 | 実 | 1,296,163 | ↓ | -2.0% | -2.0% | 155,686 | ↓ | -28.6% | -41.3% | 156,886 | ↓ | -27.4% | -40.3% | 124,086 | ↓ | -28.7% | -40.6% |
| 2022.03 | 2022/02/02 | Q3予 | 1,323,000 | → | 0.0% | 0.0% | 218,000 | → | 0.0% | -17.7% | 216,000 | → | 0.0% | -17.9% | 174,000 | → | 0.0% | -16.7% |
| 2022.03 | 2021/10/29 | Q2予 | 1,323,000 | → | 0.0% | 0.0% | 218,000 | ↓ | -4.0% | -17.7% | 216,000 | ↓ | -4.0% | -17.9% | 174,000 | ↓ | -4.9% | -16.7% |
| 2022.03 | 2021/07/30 | Q1予 | 1,323,000 | → | 0.0% | 0.0% | 227,000 | ↓ | -14.3% | -14.3% | 225,000 | ↓ | -14.4% | -14.4% | 183,000 | ↓ | -12.4% | -12.4% |
| 2022.03 | 2021/04/27 | 当初予 | 1,323,000 | - | - | - | 265,000 | - | - | - | 263,000 | - | - | - | 209,000 | - | - | - |
| 2021.03 | 2021/04/27 | 実 | 1,249,528 | ↓ | -0.6% | -2.5% | 136,051 | ↓ | -35.4% | -47.1% | 145,324 | ↓ | -30.6% | -43.2% | 120,589 | ↓ | -28.9% | -41.5% |
| 2021.03 | 2021/01/29 | Q3予 | 1,256,500 | → | 0.0% | -2.0% | 210,500 | → | 0.0% | -18.1% | 209,500 | → | 0.0% | -18.2% | 169,500 | → | 0.0% | -17.7% |
| 2021.03 | 2020/10/30 | Q2予 | 1,256,500 | → | 0.0% | -2.0% | 210,500 | ↓ | -14.6% | -18.1% | 209,500 | ↓ | -14.7% | -18.2% | 169,500 | ↓ | -14.2% | -17.7% |
| 2021.03 | 2020/08/04 | Q1予 | 1,256,500 | ↓ | -2.0% | -2.0% | 246,500 | ↓ | -4.1% | -4.1% | 245,500 | ↓ | -4.1% | -4.1% | 197,500 | ↓ | -4.1% | -4.1% |
| 2021.03 | 2020/05/14 | 当初予 | 1,282,000 | - | - | - | 257,000 | - | - | - | 256,000 | - | - | - | 206,000 | - | - | - |
| 2020.03 | 2020/05/14 | 実 | 1,300,843 | ↑ | +3.6% | +6.3% | 243,991 | ↓ | -7.2% | +6.5% | 245,350 | ↓ | -6.7% | +6.7% | 195,411 | ↓ | -6.9% | +7.4% |
| 2020.03 | 2020/01/31 | Q3予 | 1,256,000 | → | 0.0% | +2.6% | 263,000 | → | 0.0% | +14.8% | 263,000 | → | 0.0% | +14.3% | 210,000 | → | 0.0% | +15.4% |
| 2020.03 | 2019/10/31 | Q2予 | 1,256,000 | ↑ | +2.6% | +2.6% | 263,000 | ↑ | +14.8% | +14.8% | 263,000 | ↑ | +14.3% | +14.3% | 210,000 | ↑ | +15.4% | +15.4% |
| 2020.03 | 2019/07/30 | Q1予 | 1,224,000 | → | 0.0% | 0.0% | 229,000 | → | 0.0% | 0.0% | 230,000 | → | 0.0% | 0.0% | 182,000 | → | 0.0% | 0.0% |
| 2020.03 | 2019/04/25 | 当初予 | 1,224,000 | - | - | - | 229,000 | - | - | - | 230,000 | - | - | - | 182,000 | - | - | - |
| 2019.03 | 2019/04/25 | 実 | 1,306,348 | ↑ | +0.5% | +2.2% | 243,912 | ↑ | +4.2% | -8.0% | 248,967 | ↑ | +5.5% | -6.4% | 222,265 | ↑ | +14.0% | +4.3% |
| 2019.03 | 2019/01/31 | Q3予 | 1,300,000 | → | 0.0% | +1.7% | 234,000 | → | 0.0% | -11.7% | 236,000 | → | 0.0% | -11.3% | 195,000 | → | 0.0% | -8.5% |
| 2019.03 | 2018/10/31 | Q2予 | 1,300,000 | ↑ | +1.7% | +1.7% | 234,000 | ↓ | -11.7% | -11.7% | 236,000 | ↓ | -11.3% | -11.3% | 195,000 | ↓ | -8.5% | -8.5% |
| 2019.03 | 2018/07/27 | Q1予 | 1,278,000 | - | - | - | 265,000 | - | - | - | 266,000 | - | - | - | 213,000 | - | - | - |
| 2018.03 | 2018/01/31 | Q3予 | 1,297,000 | → | 0.0% | +1.4% | 222,000 | → | 0.0% | -12.6% | 228,000 | → | 0.0% | -12.3% | 180,000 | → | 0.0% | -9.1% |
| 2018.03 | 2017/10/31 | Q2予 | 1,297,000 | ↑ | +1.4% | +1.4% | 222,000 | ↓ | -12.6% | -12.6% | 228,000 | ↓ | -12.3% | -12.3% | 180,000 | ↓ | -9.1% | -9.1% |
| 2018.03 | 2017/07/28 | Q1予 | 1,279,000 | → | 0.0% | 0.0% | 254,000 | → | 0.0% | 0.0% | 260,000 | → | 0.0% | 0.0% | 198,000 | → | 0.0% | 0.0% |
| 2018.03 | 2017/04/27 | 当初予 | 1,279,000 | - | - | - | 254,000 | - | - | - | 260,000 | - | - | - | 198,000 | - | - | - |
| 2017.03 | 2017/04/27 | 実 | 1,311,665 | ↑ | +0.9% | -2.8% | 260,830 | ↓ | -2.3% | -2.3% | 281,769 | ↑ | +5.1% | +5.1% | 218,701 | ↑ | +10.5% | +11.0% |
| 2017.03 | 2017/01/31 | Q3予 | 1,300,000 | → | 0.0% | -3.7% | 267,000 | → | 0.0% | 0.0% | 268,000 | → | 0.0% | 0.0% | 198,000 | → | 0.0% | +0.5% |
| 2017.03 | 2016/10/28 | Q2予 | 1,300,000 | ↓ | -3.7% | -3.7% | 267,000 | → | 0.0% | 0.0% | 268,000 | → | 0.0% | 0.0% | 198,000 | ↑ | +0.5% | +0.5% |
| 2017.03 | 2016/07/29 | Q1予 | 1,350,000 | - | - | - | 267,000 | - | - | - | 268,000 | - | - | - | 197,000 | - | - | - |
| 2016.03 | 2016/01/29 | Q3予 | 1,384,000 | → | 0.0% | +1.6% | 229,000 | → | 0.0% | -3.8% | 242,000 | → | 0.0% | +1.3% | 172,000 | → | 0.0% | +1.2% |
| 2016.03 | 2015/10/30 | Q2予 | 1,384,000 | ↑ | +1.6% | +1.6% | 229,000 | ↓ | -3.8% | -3.8% | 242,000 | ↑ | +1.3% | +1.3% | 172,000 | ↑ | +1.2% | +1.2% |
| 2016.03 | 2015/07/31 | Q1予 | 1,362,000 | → | 0.0% | 0.0% | 238,000 | → | 0.0% | 0.0% | 239,000 | → | 0.0% | 0.0% | 170,000 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/11 | 当初予 | 1,362,000 | - | - | - | 238,000 | - | - | - | 239,000 | - | - | - | 170,000 | - | - | - |
| 2015.03 | 2015/05/11 | 実 | 1,247,259 | ↑ | +3.1% | +4.6% | 185,663 | ↓ | -11.6% | -10.7% | 189,683 | - | - | - | 135,856 | - | - | - |
| 2015.03 | 2015/02/02 | Q3予 | 1,210,000 | → | 0.0% | +1.5% | 210,000 | → | 0.0% | +1.0% | - | - | - | - | - | - | - | - |
| 2015.03 | 2014/10/31 | Q2予 | 1,210,000 | ↑ | +1.5% | +1.5% | 210,000 | ↑ | +1.0% | +1.0% | - | - | - | - | - | - | - | - |
| 2015.03 | 2014/08/01 | Q1予 | 1,192,000 | → | 0.0% | 0.0% | 208,000 | → | 0.0% | 0.0% | - | - | - | - | - | - | - | - |
| 2015.03 | 2014/05/12 | 当初予 | 1,192,000 | - | - | - | 208,000 | - | - | - | - | - | - | - | - | - | - | - |
| 2014.03 | 2014/05/12 | 実 | 1,139,909 | - | - | - | 116,806 | - | - | - | 121,975 | - | - | - | 90,874 | - | - | - |
